Outcomes After Endovascular Aortic Intervention in Patients With Connective Tissue Disease

Author:

Olsson Karl Wilhelm1,Mani Kevin1,Burdess Anne1,Patterson Suzannah2,Scali Salvatore T.2,Kölbel Tilo3,Panuccio Giuseppe3,Eleshra Ahmed3,Bertoglio Luca4,Ardita Vincenzo4,Melissano Germano4,Acharya Amish5,Bicknell Colin5,Riga Celia5,Gibbs Richard5,Jenkins Michael5,Bakthavatsalam Arvind6,Sweet Matthew P.6,Kasprzak Piotr M.7,Pfister Karin7,Oikonomou Kyriakos78,Heloise Tessely9,Sobocinski Jonathan9,Butt Talha10,Dias Nuno10,Tang Ching11,Cheng Stephen W. K.12,Vandenhaute Sarah13,Van Herzeele Isabelle13,Sorber Rebecca A.14,Black James H.14,Tenorio Emanuel R.15,Oderich Gustavo S.15,Vincent Zoë16,Khashram Manar16,Eagleton Matthew J.17,Pedersen Steen Fjord18,Budtz-Lilly Jacob18,Lomazzi Chiara19,Bissacco Daniele19,Trimarchi Santi1920,Huerta Abigail21,Riambau Vincent21,Wanhainen Anders122

Affiliation:

1. Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

2. Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville

3. Department of Vascular Medicine, German Aortic Center, University Heart Center, Hamburg, Germany

4. Division of Vascular Surgery, Vita Salute San Raffaele University, San Raffaele Hospital, Milano, Italy

5. Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, United Kingdom

6. Division of Vascular Surgery, Department of Surgery, University of Washington Medical Center, Seattle

7. Department of Vascular and Endovascular Surgery, University Medical Centre Regensburg, Regensburg, Germany

8. Department of Vascular and Endovascular Surgery, Cardiovascular Surgery Clinic, University Hospital Frankfurt and Johann Wolfgang Goethe University Frankfurt, Frankfurt, Germany

9. Department of Vascular Surgery, Centre Hospitalier Universitaire de Lille, Lille, France

10. Vascular Center, Skåne University Hospital and Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden

11. Department of Surgery, Queen Mary Hospital, Hong Kong, China

12. Division of Vascular & Endovascular Surgery, Department of Surgery, University of Hong Kong Medical Centre, Hong Kong, China

13. Department of Thoracic and Vascular Surgery, Ghent University Hospital, Ghent, Belgium

14. Department of Vascular Surgery and Endovascular Therapy, Johns Hopkins Hospital, Baltimore, Maryland

15. Department of Cardiothoracic & Vascular Surgery, Advanced Aortic Research Program at the University of Texas Health Science Center at Houston, McGovern Medical School, Houston

16. Department of Vascular Surgery, Waikato Hospital, University of Auckland, Hamilton, New Zealand

17. Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, Massachusetts

18. Division of Vascular Surgery, Department of Cardiovascular Sugery, Aarhus University Hospital, Aarhus, Denmark

19. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

20. Department of Clinical and Community Sciences, University of Milan, Milan, Italy

21. Vascular Surgery Department, CardioVascular Institute, Hospital Clinic, Barcelona, Spain

22. Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden

Abstract

ImportanceEndovascular treatment is not recommended for aortic pathologies in patients with connective tissue diseases (CTDs) other than in redo operations and as bridging procedures in emergencies. However, recent developments in endovascular technology may challenge this dogma.ObjectiveTo assess the midterm outcomes of endovascular aortic repair in patients with CTD.Design, Setting, and ParticipantsFor this descriptive retrospective study, data on demographics, interventions, and short-term and midterm outcomes were collected from 18 aortic centers in Europe, Asia, North America, and New Zealand. Patients with CTD who had undergone endovascular aortic repair from 2005 to 2020 were included. Data were analyzed from December 2021 to November 2022.ExposureAll principal endovascular aortic repairs, including redo surgery and complex repairs of the aortic arch and visceral aorta.Main Outcomes and MeasuresShort-term and midterm survival, rates of secondary procedures, and conversion to open repair.ResultsIn total, 171 patients were included: 142 with Marfan syndrome, 17 with Loeys-Dietz syndrome, and 12 with vascular Ehlers-Danlos syndrome (vEDS). Median (IQR) age was 49.9 years (37.9-59.0), and 107 patients (62.6%) were male. One hundred fifty-two (88.9%) were treated for aortic dissections and 19 (11.1%) for degenerative aneurysms. One hundred thirty-six patients (79.5%) had undergone open aortic surgery before the index endovascular repair. In 74 patients (43.3%), arch and/or visceral branches were included in the repair. Primary technical success was achieved in 168 patients (98.2%), and 30-day mortality was 2.9% (5 patients). Survival at 1 and 5 years was 96.2% and 80.6% for Marfan syndrome, 93.8% and 85.2% for Loeys-Dietz syndrome, and 75.0% and 43.8% for vEDS, respectively. After a median (IQR) follow-up of 4.7 years (1.9-9.2), 91 patients (53.2%) had undergone secondary procedures, of which 14 (8.2%) were open conversions.Conclusions and RelevanceThis study found that endovascular aortic interventions, including redo procedures and complex repairs of the aortic arch and visceral aorta, in patients with CTD had a high rate of early technical success, low perioperative mortality, and a midterm survival rate comparable with reports of open aortic surgery in patients with CTD. The rate of secondary procedures was high, but few patients required conversion to open repair. Improvements in devices and techniques, as well as ongoing follow-up, may result in endovascular treatment for patients with CTD being included in guideline recommendations.

Publisher

American Medical Association (AMA)

Subject

Surgery

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3